Ignite Creation Date:
2024-05-05 @ 5:12 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00403962
Status:
COMPLETED
Last Update Posted:
2016-09-15
First Post:
2005-08-29
Brief Title:
A Combination Therapy In Patients With Social Anxiety Disorder
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Study Overview
Official Title:
A Randomised Double-Blind Parallel-Group Placebo-Controlled Fixed Dose Study Comparing the Efficacy and Safety of GW597599Paroxetine Combination or Paroxetine Monotherapy to Placebo in Patients With Social Anxiety Disorder SAD
Status:
COMPLETED
Status Verified Date:
2016-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to assess the efficacy safety and tolerability of a combination of Vestipitant and Paroxetine in patients with Social Anxiety Disorder SAD
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None